Immunovant, Inc. (a Delaware corporation) 7,370,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 28th, 2023 • Immunovant, Inc. • Biological products, (no disgnostic substances) • New York
SHARE PURCHASE AGREEMENTShare Purchase Agreement • September 28th, 2023 • Immunovant, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SHARE PURCHASE AGREEMENT (this “Agreement”), dated as of September 26, 2023, by and between ROIVANT SCIENCES LTD. (the “Investor”), a Bermuda exempted limited company, and IMMUNOVANT, INC. (the “Company”), a Delaware corporation. The Investor and the Company are collectively referred to as the “Parties.”
